Y. Lim

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population.

J. Y. Park, Jae-Gook Shin, J. Shon, 2001, British journal of clinical pharmacology.

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

Chung-Han Lee, Kwang-Hyeon Liu, Jae-Gook Shin, 2005, British journal of clinical pharmacology.

Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans.

D. Flockhart, Ji-Young Park, Jae-Gook Shin, 2002, Pharmacogenetics.